Skip to content
Search AI Powered

Latest Stories

Costs and Accessibility of MSC Therapy for Parkinson’s Disease

Exploring Mesenchymal Stem Cells and Their Accessibility in Parkinson’s Disease Treatment

Parkinson’s disease is a progressive neurodegenerative disorder in which the patient has various motor symptoms. In the later Parkinson’s disease stages, the motor symptoms worsen, and the patient also develops nonmotor symptoms. 

Parkinson’s disease is believed to be caused due to the loss of dopaminergic neurons in the substantia nigra pars compacta, which is part of the basal ganglia. The loss of neurons leads to movement slowing, as seen in Parkinson’s disease. Patients with Parkinson’s disease have characteristic symptoms such as bradykinesia (slow movements), rigidity, resting tremors, walking instability, and falls. Some non-motor symptoms include expressionless faces, sleep disturbances, depression, and cognitive decline. 


Although the mechanism of Parkinson’s disease is understood to a certain extent, the current treatments only slow down the process for a bit before becoming ineffective. But with stem cells, researchers hope to change the landscape of Parkinson’s disease treatment options and hopefully provide patients with an option that not only significantly slows down disease progression but also manages to improve them.

Understanding the Financial Aspects of MSC Therapy for Parkinson’s Disease

Mesenchymal stem cell therapy is not new, but its use for Parkinson’s disease is somewhat new. It is also more costly than the normally used treatment options, oral medicines. 

MSC therapy requires a lot of steps and procedures, and to ensure the procedure's safety, a lot of money is spent on the technology. MSC is not as simple as extracting and injecting cells into the patient. Some various steps and conditions need to be taken care of. 

When the cells are extracted, whether from the patient or the donor, they must be extracted carefully and in a sterile environment. Then, they must be cultured with the appropriate growth factor before being injected into the patient. If, at any point, something goes wrong, the entire procedure fails. So, higher costs also ensure higher success rates. 

The cost is not just for the procedure but also for evaluations before and after the procedure. So, patients must spend money to get tested to ensure they are suitable candidates. After the procedure, they must follow up with the doctor regularly to ensure that everything is going to plan. All this adds to the cost, too. 

What factors determine the cost of MSC Therapy for Parkinson’s Disease?

Like any treatment option, various factors determine the cost of stem cell therapy for Parkinson’s disease. Five significant factors influence the cost of the therapy. These factors are –

  1. The type of cells used.
  2. The sourcing of the cells.
  3. The number of cells acquired.
  4. The lab in which the cells are cultured.
  5. The quality of the cells used. 

Adult stem cells, such as mesenchymal stem cells, are cheaper than embryonic stem cells, but the cost is still high. These procedures are also conducted in highly regulated and top-of-the-line labs and facilities, which further adds to the cost of the procedure. 

Unlike a simple procedure for localized pain, the injection of stem cells for Parkinson’s disease is more complex, adding to the cost. 

Does insurance cover MSC Therapy for Parkinson’s Disease treatment?

Currently, very few stem cell therapies are covered by insurance, and unfortunately, stem cell therapy for Parkinson’s disease is not one of them. However, you should consult various insurance providers to see what can be done.

How accessible is MSC Therapy for Parkinson’s Disease?

Since using stem cells to treat Parkinson’s disease is new, the therapy is not available as widely as some other stem cell therapies. It is also not available for patients at all Parkinson’s disease stages, as the results are better when treatment is undergone at an earlier stage. 

But, there are still various places conducting this treatment that can produce promising results. You can find even more information about it by consulting experts at Swiss Medica Clinics.

What are the potential financial and logistical challenges of pursuing MSC Therapy for Parkinson’s Disease?

One of the biggest hurdles from a patient’s perspective is the cost of the therapy. It is also not a simple procedure that can be done in a single day and requires a lot of testing and follow-up visits. 

Even if the cells are taken from the patient themselves, the procedures are rather complex and require a lot of technology, optimum storage, and working conditions to ensure the best results. The injection of these cells into the patient after being replicated is also a complex task and requires a lot of expertise. So, the procedure is only offered by a handful of reputable institutes. 

Affordability and Accessibility of Mesenchymal Stem Cell Therapy for Parkinson’s Disease

Neurodegenerative diseases like Parkinson’s disease can be very difficult for both the patient and their family. But with advancements in science and new treatment options like stem cell therapy, there is hope for these patients. 

Although the cost of stem cells to treat Parkinson’s disease are not minimal, the results can be rather promising. They can help improve the patient’s quality of life rather significantly. If you are in need of such a treatment, you can check out one of the most prominent clinics in this field, Swiss Medica in order to receive more information.

More For You

Wes Streeting: Musk's intervention in UK politics 'misinformed'

Wes Streeting arrives to attend the weekly Cabinet meeting in 10 Downing Street on December 3, 2024 in London, England. (Photo by Carl Court/Getty Images)

Wes Streeting: Musk's intervention in UK politics 'misinformed'

A senior minister has criticised Elon Musk's latest intervention in the country's politics as "misjudged and certainly misinformed".

The tech billionaire accused prime minister Keir Starmer a day earlier of failing to bring "rape gangs" to justice when he was director of public prosecutions.

Keep ReadingShow less
Vice-chancellors at top universities spent £1m on foreign trips

Vice-chancellors at the 24 Russell Group universities have claimed significant amounts for trips abroad, luxury hotels, and even home renovations. (Photo by Christopher Furlong/Getty Images)

Vice-chancellors at top universities spent £1m on foreign trips

LEADERS at some of the UK's most prestigious universities have spent close to £1 million on international travel over the past three years, despite ongoing warnings about financial challenges within the higher education sector.

An analysis by The Times revealed that vice-chancellors at the 24 Russell Group universities, representing the country’s most renowned universities, have claimed significant amounts for trips abroad, luxury hotels, and even home renovations.

Keep ReadingShow less
Jaideep Ahlawat

The series is written and created by Sudip Sharma, with the second season directed by Avinash Arun Dhaware. (Photo: X/@PrimeVideoIN)

Prime Video releases first teaser for 'Paatal Lok' season 2

STREAMING platform Prime Video has released the teaser for the second season of its popular series, Paatal Lok.

The teaser, shared on Prime Video’s official social media pages on Friday, features actor Jaideep Ahlawat reprising his role as Hathi Ram Chaudhary, a police inspector entangled in gripping mysteries.

Keep ReadingShow less
Neil-Young-Getty

Young last performed at Glastonbury in 2009. (Photo: Getty Images)

Neil Young confirms Glastonbury performance after initial withdrawal

FOLK musician Neil Young has reversed his earlier decision to pull out of the Glastonbury music festival and will now headline the event, he announced alongside festival organisers on Friday.

Young had initially withdrawn from the festival, citing concerns over its "corporate control" through its association with the BBC. However, he later clarified that the decision was based on "an error in the information I received."

Keep ReadingShow less
The benefits of voluntary VAT registration

The benefits of voluntary VAT registration

When starting a business, one of the more confusing decisions you have to make is whether to voluntarily register for VAT (Value Added Tax). In the UK, businesses must register for VAT with HMRC once their taxable turnover exceeds the threshold of £90,000. However, many businesses choose to register even if they don’t meet this threshold.

While it might seem unnecessary, voluntary VAT registration actually has many benefits that can significantly benefit small and medium-sized businesses.

Keep ReadingShow less